{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:24:52Z","timestamp":1792801492816,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.euroneuro.2014.04.009","type":"journal-article","created":{"date-parts":[[2014,5,10]],"date-time":"2014-05-10T00:34:37Z","timestamp":1399682077000},"page":"1362-1370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["5-hydroxytryptamine- and dopamine-releasing effects of ring-substituted amphetamines on rat brain: A comparative study using in vivo microdialysis"],"prefix":"10.1016","volume":"24","author":[{"given":"T.","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Maeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Seko-Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Monma-Ohtaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ishiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2014.04.009_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0028-3908(86)90055-9","article-title":"Selective inhibition of monoamine oxidase by p-aminosubstituted phenylalkylamines in catecholaminergic neurones","volume":"25","author":"Ask","year":"1986","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2014.04.009_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0893-133X(01)00345-1","article-title":"Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B\/1D) and 5-HT(2) receptors","volume":"26","author":"Bankson","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.04.009_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0014-2999(88)90056-8","article-title":"Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites","volume":"149","author":"Battaglia","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0091-3057(88)90155-4","article-title":"MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons","volume":"29","author":"Battaglia","year":"1988","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1124\/jpet.110.176271","article-title":"In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the rat","volume":"337","author":"Baumann","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bcp.2007.07.018","article-title":"The behavioral pharmacology of hallucinogens","volume":"75","author":"Fantegrossi","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00213-006-0453-9","article-title":"The effects of the 5-HT(2C) receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists","volume":"187","author":"Fletcher","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.04.009_bib8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0028-3908(75)90099-4","article-title":"Comparison of 4-chloro-, 4-bromo- and 4-fluoroamphetamine in rats: drug levels in brain and effects on brain serotonin metabolism","volume":"14","author":"Fuller","year":"1975","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2014.04.009_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0014-2999(75)90145-4","article-title":"Reversible and irreversible phases of serotonin depletion by 4-chloroamphetamine","volume":"33","author":"Fuller","year":"1975","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib10","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0028-3908(74)90050-1","article-title":"Effects of some homologues of 4-chloroamphetamine on brain serotonin metabolism","volume":"13","author":"Fuller","year":"1974","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2014.04.009_bib11","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1021\/jm0493109","article-title":"Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling","volume":"48","author":"Gallardo-Godoy","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0022-3565(25)20965-X","article-title":"Effects of repeated administration of 3,4-methylenedioxymethamphetamine on 5-hydroxytryptamine neuronal activity and release in the rat brain in vivo","volume":"279","author":"Gartside","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib13","first-page":"25","article-title":"Discriminative stimulus properties of hallucinogens and related designer drugs","volume":"116","author":"Glennon","year":"1991","journal-title":"NIDA. Res. Monogr."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0091-3057(99)00045-3","article-title":"Arylalkylamine drugs of abuse: an overview of drug discrimination studies","volume":"64","author":"Glennon","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib15","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1021\/jm00352a013","article-title":"Behavioral and serotonin receptor properties of 4-substituted derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane","volume":"25","author":"Glennon","year":"1982","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0091-3057(96)00306-1","article-title":"Initial characterization of PMMA as a discriminative stimulus","volume":"57","author":"Glennon","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0091-3057(91)90137-Q","article-title":"Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate","volume":"39","author":"Gough","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib18","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1749-6632.2002.tb04182.x","article-title":"Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study","volume":"965","author":"Gough","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib19","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.2042-7158.1980.tb12909.x","article-title":"p-Methoxyamphetamine, a potent reversible inhibitor of type-A monoamine oxidase in vitro and in vivo","volume":"32","author":"Green","year":"1980","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pr.55.3.3","article-title":"The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d)","volume":"55","author":"Green","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1471-4159.1996.66010243.x","article-title":"Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions","volume":"66","author":"Gudelsky","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.pbb.2007.10.003","article-title":"Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons","volume":"90","author":"Gudelsky","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejphar.2010.10.094","article-title":"5-HT(2A) and 5-HT(2C) receptor stimulation are differentially involved in the cortical dopamine efflux-Studied in 5-HT(2A) and 5-HT(2C) genetic mutant mice","volume":"652","author":"Huang","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib24","first-page":"74","article-title":"Structure-activity relationships of the classic hallucinogens and their analogs","volume":"146","author":"Jacob","year":"1994","journal-title":"NIDA. Res. Monogr."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib25","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0091-3057(97)00527-3","article-title":"The acute effects of amphetamine derivatives on extracellular serotonin and dopamine levels in rat nucleus accumbens","volume":"59","author":"Kankaanpaa","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib26","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1111\/j.1476-5381.2011.01499.x","article-title":"Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats","volume":"164","author":"Kehr","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib27","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.pbb.2004.05.021","article-title":"Stimulus effects of three sulfur-containing psychoactive agents","volume":"78","author":"Khorana","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1254\/jphs.92.178","article-title":"Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption","volume":"92","author":"Kita","year":"2003","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0022-3565(25)29480-0","article-title":"Adrenal and striatal tyrosine hydroxylase activity after methamphetamine","volume":"185","author":"Koda","year":"1973","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib30","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0022-3565(25)20792-3","article-title":"LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex","volume":"278","author":"Marek","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0014-2999(95)00478-5","article-title":"Psychostimulant-like effects of p-fluoroamphetamine in the rat","volume":"287","author":"Marona-Lewicka","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib32","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.bjp.0704442","article-title":"The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, \u2018ecstasy\u2019) to rats","volume":"135","author":"Mechan","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2006.11.075","article-title":"The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain","volume":"559","author":"Nagai","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0014-2999(91)90664-C","article-title":"Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues","volume":"200","author":"Nash","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib35","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1046\/j.1471-4159.1996.67062521.x","article-title":"Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs","volume":"67","author":"Newton","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","article-title":"Hallucinogens","volume":"101","author":"Nichols","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib37","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1021\/jm00051a011","article-title":"1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: a potent serotonin 5-HT2A\/2C agonist","volume":"37","author":"Nichols","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib38","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.euroneuro.2014.04.009_bib39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0379-0738(98)00214-X","article-title":"Analytical profile of 4-methylthioamphetamine (4-MTA), a new street drug","volume":"100","author":"Poortman","year":"1999","journal-title":"Forensic. Sci. Int."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF03033330","article-title":"Neurochemical and behavioural characterisation of alkoxyamphetamine derivatives in rats","volume":"10","author":"Romero","year":"2006","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0022-3565(25)30027-3","article-title":"Long-term effects of p-chloroamphetamine and related drugs on central serotonergic mechanisms","volume":"192","author":"Sanders-Bush","year":"1975","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)22673-8","article-title":"Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine","volume":"240","author":"Schmidt","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib43","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1016\/0006-2952(87)90566-1","article-title":"Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine","volume":"36","author":"Schmidt","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib44","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0014-2999(86)90140-8","article-title":"Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue","volume":"124","author":"Schmidt","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib45","first-page":"537","article-title":"Monoamine oxidase inhibitory properties of some methoxylated and alkylthio amphetamine derivatives: structure-activity relationships","volume":"221","author":"Scorza","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib46","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/221537a0","article-title":"Structure-activity relationships of one-ring psychotomimetics","volume":"221","author":"Shulgin","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2014.04.009_bib47","series-title":"PiHKAL: A Chemical Love Story","author":"Shulgin","year":"1991"},{"key":"10.1016\/j.euroneuro.2014.04.009_bib48","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/0006-2952(87)90594-6","article-title":"Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain","volume":"36","author":"Steele","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib49","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/0028-3908(87)90117-1","article-title":"Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat","volume":"26","author":"Stone","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2014.04.009_bib50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0014-2999(86)90555-8","article-title":"The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain","volume":"128","author":"Stone","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00176847","article-title":"Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens","volume":"94","author":"Titeler","year":"1988","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.euroneuro.2014.04.009_bib52","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0022-3565(25)09555-2","article-title":"Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra","volume":"273","author":"Yamamoto","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2014.04.009_bib53","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/med.2610060105","article-title":"Discriminative stimulus properties of amphetamine and structurally related phenalkylamines","volume":"6","author":"Young","year":"1986","journal-title":"Med. Res. Rev."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X1400131X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X1400131X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T17:41:13Z","timestamp":1746207673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X1400131X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0924977X1400131X"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.04.009","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-hydroxytryptamine- and dopamine-releasing effects of ring-substituted amphetamines on rat brain: A comparative study using in vivo microdialysis","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}